Inkinga Yengqondo Yokunakekelwa Kwezinhlungu
Abantu abadala nabagijimi benza umsebenzi wokuzikhandla ngokuvame ukudala ukubambezeleka kwe-muscle soreness (DOMS). Ngezinye izikhathi lokhu kuphazamiseka kudinga okungaphezulu nje kokugeza okunethezeka kosawoti e-Epsom. Abantu abaningi bazosebenzisa izidakamizwa ezingezona ukuvuvukala (ama-NSAID) okungewona ama-nonsteroidal. Ama-NSAID angathengwa phezu kwe-counter (OTC) kunoma isiphi isitolo sendawo.
Abathengi bavame ukuzizwa ngalezizindleko ze-counter (OTC) eziphephile kunezidakamizwa zemithi. Sithenga izidakamizwa ze-OTC ezihlanganisa ama-NSAID ngaphandle kokukhathazeka ukuthi zingase zibe yingozi. Iningi lamakhaya liyoba nebhokisi le-Ibuprofen noma enye i-NSAID yokuphumula ubuhlungu futhi ihlanganise nabambalwa ngaphandle kokucabanga nganoma yimiphi imiphumela embi yempilo.
Kufanele Ngikhathazeke?
Ngokusho kwe-Federal Drug Administration (FDA), izidakamizwa ezingekho-steroidal ezilwa nokuvuvukala (ama-NSAID) zingakhuphula ingozi yokuhlaselwa yinhliziyo noma isifo sohlangothi. Ngenxa yalesi simemezelo sokuphepha yi-FDA, kunconywa ukuba uhlale uvikelekile futhi unciphise ukusetshenziswa kwethu kwama-NSAID njengo-Ibuprofen. Okungenani, kufanele sixoxe ngokuthatha ama-NSAID nodokotela wethu.
Ngaphansi kwe-counter (OTC) kanye nezidakamizwa ezingavumelekile zokulwa nezidakamizwa (i-NSAID) ziqhubeka zicwaningwa kabanzi ngenxa yezixhumanisi zengozi yokuhlasela kwenhliziyo nezinkinga ezinzima zamathumbu. Okunye okufundwa ngophenyo kwakungavumelekile ukusetshenziswa kwe-NSAID ngokweqile elishicilelwe kuyi- Journal of Clinical Medicine and Research . Ngokusobala, ama-NSAID abe yingxenye ebalulekile kwimicimbi ye-cardiovascular. Odokotela nodokotela nabo babelulekwa ukuba bahlale beqaphe lapho bebeka ama-NSAID kuziguli zabo.
Yenza Ucwaningo Lwakho
I-Federal Drug Administration (FDA) ngumthombo omuhle kakhulu wolwazi kubathengi, ikakhulukazi ukudla okunempilo nezixwayiso ezithile zezidakamizwa. Kungumqondo omuhle ukuhlola ngezikhathi ezithile i-FDA ngezinto ezingase zibe yingozi empilweni yethu. Ngaphandle kokwenza ucwaningo lwethu ngokudla, ukuxhaswa, nobuhlungu obukhululeka njenge-NSAID, ngokuvamile sishiywa ebumnyameni nganoma yikuphi ukukhathazeka kokuphepha.
Ngokusho komunye ucwaningo, ama-NSAID angaphinda aphikiselwe labo ababhekene nezimo ezithile zezokwelapha. Kubonakala sengathi abantu abane-hypertension noma izimo zenhliziyo ezikhona basengozini enkulu yokwanda kwezindaba zezempilo besebenzisa izidakamizwa ezingezona ukuvuvukala (ama-NSAID). Ucwaningo oluqhubekayo olwenziwe ezigulini ezine-heart attack ngaphambili lisiphakamise nokuthi ukusetshenziswa kwesikhathi esifushane kwama-NSAID kwabeka umuntu engozini eyengeziwe yokwehla kwenhliziyo noma ukufa.
Izincomo ezihlukile eziboniswe kulabo abanezimo zenhliziyo ezikhona zihlanganisa i-acetaminophen, isithako esivamile eTylenol sokusizwa ubuhlungu. I-Tylenol ingase ibe ngcono kangcono kodwa ngaphambi kokuthatha lokhu noma noma iyiphi enye inketho, kubalulekile ukuba nengxoxo nodokotela wakho.
Ama-NSAID avamile
Ngaphezu kwezidakamizwa eziphikisana nezidakamizwa ezingekho ukuvuvukala (ama-NSAID) ziye zithandwa iminyaka eminingi zinikeza ukuphumula okuphumelelayo kwemizimba, imisipha, i-sprains, ikhanda nokukhwabanisa. Abaningi bethu babheka ama-NSAID umngane omkhulu womdlali uma kuziwa ekunciphiseni ubuhlungu. Kubonakala sengathi izingozi zempilo manje zingaphezu kwezinzuzo. Okulandelayo yi-NSAID evamile evunyelwe e-United States futhi iyatholakala ngaphandle kwemithi:
- Ibuprofen (igama elijwayelekile le-Advil ne-Motrin)
- I-Naproxen sodium (igama elivamile le-Aleve)
- I-Aspirin (igama elivamile le-Ascriptin, i-Bayer, i-Ecotrin)
Ezinye imithi ye-OTC ebandayo ibandakanya ama-NSAID ngokusho kwe-Federal Drug Administration (FDA). I-FDA iphinde ikhombise ukuthi akukho nhlobo yokusebenzisa i-NSAID iboniswa ukuthi ingenakho ingozi.
Ingabe kufanele ngithathe ama-NSAID?
Ukulawulwa Kwezokudla Nezidakamizwa (FDA) akusho ukuyeka ukuthatha ama-NSAID kodwa unikeze isimemezelo sokuphepha kolwazi. Bazwa ubufakazi obanele beqoqwe ukuze batshele abathengi ukuthi kungenzeka yini ama-NSAID ukukhulisa ingozi yokuhlasela kwenhliziyo nokushaywa yisifo sohlangothi. Okuhle mayelana nesaziso se-FDA sohlelo lwe-NSAID ukuqwashiswa kwabathengi. Ivumela ikhono lokwenza isinqumo esinolwazi mayelana nezidakamizwa ezingekho emthethweni (anti-inflammatory drugs) nama-NSAID) kanye nempilo yethu.
Ukukhetha ukuthatha izidakamizwa eziphikisana nezidakamizwa (anti-inflammatory drugs) (NSAIDs) kuhlale kuyisinqumo somuntu siqu esinconywe ukuba sikhulunywe nodokotela wakho. Ama-NSAID aboniswa futhi ukuthi anikeze ukuphumula okuphumelelayo kodwa ahloselwe ukusetshenziselwa isikhathi esifushane kungakapheli izinsuku eziyishumi. Ukusebenzisa ama-NSAID ngezikhathi ezinde kufanele kwenziwe ngaphansi kokunakekelwa udokotela ongakwazi ukuqapha noma yimiphi imiphumela embi yempilo.
> Imithombo:
I-CKS Ong et al., Isibuyekezo Esisekelwe Ebufakazi Ezidakamizwa Eziphikisana Nezifo Eziphikisayo, I- Journal of Medicical Medicine and Research , 2007
> Ukuphathwa Kwezokudla Nezidakamizwa, Ukubuyekezwa Kwabathengi, i-FDA Yenza Isixwayiso Sokuhlasela Kwesifo Sokushaya Kwesifo Ne-Stroke Risk ye-Non-Steroidal Anti-Inflammatory Drugs, ngo-2015
> Ukuphathwa Kwezokudla Nezidakamizwa zase-US, i-FDA Yezokuphepha Ukuxhumana Nezidakamizwa: I-FDA iqinisa isixwayiso sokuthi izidakamizwa ezingekho-aspirin ezingavumeli ukuvuvukala (ama-NSAID) zingabangela ukuhlaselwa yinhliziyo noma ukushaywa yisifo senhliziyo, ngo-2015
> Anne-Marie Schjerning Olsen, MB et al., Isikhathi Sokwelashwa Ngezidakamizwa Ezingafuni Ukuvimbela Amantombazane kanye Nezimo Ezingozi Ekufeni Nokusinda KwamaMyocardial Infarction Ezigulini Ezihamba Ngaphambi Kwama-Myocardial Infarction: Ucwaningo Lwase-National Cohort, i- American Heart Association Journals , 2011